BioLife Solutions Inc. (BLFS) |
|
16.16 0.76 (4.94%)
|
02-15 16:00 |
|
Open: |
15.43 |
Pre. Close: |
15.4 |
|
High:
|
16.16 |
Low:
|
15.43 |
|
Volume:
|
94,089 |
Market Cap:
|
299M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
16.183 - 16.274 |
16.274 - 16.357 |
|
Low:
|
15.195 - 15.311 |
15.311 - 15.418 |
|
Close:
|
15.986 - 16.16 |
16.16 - 16.319 |
|
|
|
Technical analysis |
as of: 2019-02-15 4:36:41 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 20.38 One year: 23.81 |
| Support: |
Support1: 13.83 Support2: 11.60 |
| Resistance: |
Resistance1: 17.45 Resistance2: 20.38 |
| Pivot: |
15.47 |
| Moving Average: |
MA(5): 16.07 MA(20): 14.79
MA(100): 12.82  MA(250): 12.70 |
| MACD: |
MACD(12,26): 1.03 Signal(9): 1.04 |
| Stochastic oscillator: |
%K(14,3): 69.17 %D(3): 73.06 |
| RSI: |
RSI(14): 62.02 |
| 52-week: |
High: 26.35 Low: 4.85 Change(%): 203.2 |
| Average Vol(K): |
3-Month: 15233 10-Days: 14288 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.BLFS has closed below upper band by 37.1%. Bollinger Bands are 41.7% wider than normal. The large width of the bands suggest high volatility as compared to BLFS's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
2019-01-22T09:58:00-05:00
SAVSU Technologies Launches Two New evo® Smart Shipper Models to Improve Apheresis Collection Shipments and Cryopreserved Cell and Gene Therapies
2019-01-22T08:00:00-05:00
New Policies to Advance Development of Cell and Gene Therapies Announced by FDA
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
